Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain.
Colorectal Dis. 2013 Feb;15(2):e79-83. doi: 10.1111/codi.12067.
The aim of the study was to assess the safety and feasibility of laparoscopic surgery for transverse colon cancer and to compare the clinicopathological outcome with that of conventional open surgery.
From March 1998 to December 2009, 1253 patients with colorectal tumours were operated on, 564 laparoscopically. There were 154 cases of transverse colon cancer, 86 of which were included in the study. Details were collected on age, sex, body mass index (BMI), operation time, blood loss, time to first flatus, time to resume a liquid diet, postoperative length of hospital stay, complications, TNM stage, tumour size, distal resection margin, proximal resection margin, number of nodes harvested and surgical procedure. Laparoscopic and open surgical removal was compared.
No significant differences were found between laparoscopic and conventional groups in age, sex, BMI, operation time or postoperative length of hospital stay. The mean blood loss during the operations was significantly less in the laparoscopic group (105.9 ± 140.9 ml vs 305.7 ± 325.3 ml; P = 0.05). The time to the first flatus was shorter (2.1 ± 0.3 days vs 3.8 ± 3.0 days; P = 0.043) and diet was started earlier (3.1 ± 1.4 days vs 3.4 ± 1.5 days) in the laparoscopic group. No significant differences in tumour size, proximal resection margin or number of lymph nodes were observed. The mean distal resection margin was not statistically different (10.3 ± 4.5 cm vs 8.8 ± 4.9 cm). At a mean follow up of 33 ± 2.3 months, nonport-site metastases occurred in eight patients and locoregional recurrence occurred in three, with no significant difference between the groups. The 3-year cumulative overall survival rate was 78%, and the disease-free survival rate was 69%.
There was no difference in the outcome of laparoscopic and open surgery for transverse colon cancer, including the cancer-specific outcome.
本研究旨在评估腹腔镜手术治疗横结肠癌的安全性和可行性,并将其临床病理结果与传统开腹手术进行比较。
1998 年 3 月至 2009 年 12 月,对 1253 例结直肠肿瘤患者进行了手术,其中 564 例行腹腔镜手术。横结肠癌 154 例,其中 86 例纳入研究。收集患者年龄、性别、体重指数(BMI)、手术时间、出血量、首次排气时间、恢复流质饮食时间、术后住院时间、并发症、TNM 分期、肿瘤大小、远端切缘、近端切缘、淋巴结清扫数和手术方式等详细资料。比较腹腔镜和开腹手术的切除效果。
腹腔镜组和开腹组在年龄、性别、BMI、手术时间或术后住院时间方面无显著差异。腹腔镜组术中出血量明显减少(105.9±140.9ml 比 305.7±325.3ml;P=0.05)。腹腔镜组首次排气时间更短(2.1±0.3 天比 3.8±3.0 天;P=0.043),饮食开始更早(3.1±1.4 天比 3.4±1.5 天)。两组肿瘤大小、近端切缘或淋巴结清扫数无显著差异。平均远端切缘无统计学差异(10.3±4.5cm 比 8.8±4.9cm)。平均随访 33±2.3 个月后,8 例患者出现非切口转移,3 例患者出现局部复发,但两组间无显著差异。3 年总生存率为 78%,无病生存率为 69%。
腹腔镜手术治疗横结肠癌的效果与开腹手术无差异,包括肿瘤特异性结局。